Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Franssen

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Kidney International|January 1, 1995
Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal diseaseC F Franssen, R O Gans, B Arends, et al.
Clinical and Experimental Immunology|December 21, 2000
In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG)Y M van der Geld, M G Huitema, C F Franssen, et al.
Kidney International|June 9, 2000
Antiproteinase 3- and antimyeloperoxidase-associated vasculitisC F Franssen, C A Stegeman, C G Kallenberg, et al.
Journal of the American Society of Nephrology : JASN|October 17, 1998
Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritisC F Franssen, C A Stegeman, W W Oost-Kort, et al.
Journal of the American Society of Nephrology : JASN|July 15, 1999
In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritisC F Franssen, M G Huitema, A C Muller Kobold, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Kidney International|January 1, 1995
Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal diseaseC F Franssen, R O Gans, B Arends, et al.
Clinical and Experimental Immunology|December 21, 2000
In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG)Y M van der Geld, M G Huitema, C F Franssen, et al.
Kidney International|June 9, 2000
Antiproteinase 3- and antimyeloperoxidase-associated vasculitisC F Franssen, C A Stegeman, C G Kallenberg, et al.
Journal of the American Society of Nephrology : JASN|October 17, 1998
Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritisC F Franssen, C A Stegeman, W W Oost-Kort, et al.
Journal of the American Society of Nephrology : JASN|July 15, 1999
In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritisC F Franssen, M G Huitema, A C Muller Kobold, et al.
Pageof 2